The Source Blog
Recent Action in Healthcare Costs
HB 1634 – Hawaii
Introduced: 2022 Status: Inactive / Dead
Prohibits health insurers, mutual benefit societies, and health maintenance organizations from excluding coverage of a service solely because the service is provided through telehealth and not through face-to-face contact. Requires parity between telehealth services and …
SB 82 – Georgia
Introduced: 2022 Status: Inactive / Dead
Provides each insurer shall make available on its publicly accessible website an interactive mechanism whereby any member of the public may: (1) For each health benefit policy offered, compare the payment amounts accepted by in-network …
HB 867 – Georgia
Introduced: 2022 Status: Inactive / Dead
A BILL to be entitled an Act to amend Chapter 64 of Title 33 of the Official Code of Georgia Annotated, relating to regulation and licensure of pharmacy benefits managers, so as to revise the …
HB 5082 – Connecticut
Introduced: 2022 Status: Inactive / Dead
AN ACT CONCERNING FUNDING FOR NONPROFIT COMMUNITY PROVIDERS. To provide financial support for nonprofit community providers that face increased demand for services.
SB 236 – Colorado
Introduced: 2022 Status: Enacted
Concerning the review of medicaid provider rates. Beginning August 1, 2023, the bill requires the state department to establish a schedule so that each provider rate is reviewed at least every 3 years and to …
SB 1088 – Arizona
Introduced: 2022 Status: Enacted
A health care facility with more than fifty inpatient beds must make available on request or online the direct pay price for at least the fifty most used diagnosis-related group codes, if applicable, for the …
SB 1680 – Arizona
Introduced: 2022 Status: Inactive / Dead
Establishing a Prescription drug affordability board, setting cost affordability review and upper payment limits, requiring annual report and study.
Next | See all Legislation Records
Introduced: 2022 Status: Inactive / Dead
Prohibits health insurers, mutual benefit societies, and health maintenance organizations from excluding coverage of a service solely because the service is provided through telehealth and not through face-to-face contact. Requires parity between telehealth services and …
SB 82 – Georgia
Introduced: 2022 Status: Inactive / Dead
Provides each insurer shall make available on its publicly accessible website an interactive mechanism whereby any member of the public may: (1) For each health benefit policy offered, compare the payment amounts accepted by in-network …
HB 867 – Georgia
Introduced: 2022 Status: Inactive / Dead
A BILL to be entitled an Act to amend Chapter 64 of Title 33 of the Official Code of Georgia Annotated, relating to regulation and licensure of pharmacy benefits managers, so as to revise the …
HB 5082 – Connecticut
Introduced: 2022 Status: Inactive / Dead
AN ACT CONCERNING FUNDING FOR NONPROFIT COMMUNITY PROVIDERS. To provide financial support for nonprofit community providers that face increased demand for services.
SB 236 – Colorado
Introduced: 2022 Status: Enacted
Concerning the review of medicaid provider rates. Beginning August 1, 2023, the bill requires the state department to establish a schedule so that each provider rate is reviewed at least every 3 years and to …
SB 1088 – Arizona
Introduced: 2022 Status: Enacted
A health care facility with more than fifty inpatient beds must make available on request or online the direct pay price for at least the fifty most used diagnosis-related group codes, if applicable, for the …
SB 1680 – Arizona
Introduced: 2022 Status: Inactive / Dead
Establishing a Prescription drug affordability board, setting cost affordability review and upper payment limits, requiring annual report and study.
Next | See all Legislation Records
Community Hospitals and Wellness Centers v. State of Ohio – Ohio
District Court: Common Pleas Court of Williams County Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the …
Minnesota v. Sanofi-Aventis U.S. LLC – Minnesota
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Herrera et al. v. JFK Medical Center et al. – Florida
District Court: M.D. Florida Status: Decided
In August 2014, plaintiffs filed a putative class action against multiple HCA-operated hospitals in Tampa, alleging they were charged unreasonable amounts for emergency radiological services. …
Alcon Labs., Inc. v. Cottrell – New Jersey
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation – New York
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
Next | See all Litigation Records
District Court: Common Pleas Court of Williams County Status: Decided
Ohio’s Healthcare Price Transparency Law, passed in June 2015 (HB 52) by the Ohio Legislature, has been challenged by health care providers arguing that the …
Minnesota v. Sanofi-Aventis U.S. LLC – Minnesota
District Court: District Court of New Jersey Status: Pending
Minnesota’s attorney general filed a suit accusing Sanofi, Eli Lilly, and Novo Nordisk, the three largest manufacturers of insulin, of price gouging. The lawsuit, filed in …
Herrera et al. v. JFK Medical Center et al. – Florida
District Court: M.D. Florida Status: Decided
In August 2014, plaintiffs filed a putative class action against multiple HCA-operated hospitals in Tampa, alleging they were charged unreasonable amounts for emergency radiological services. …
Alcon Labs., Inc. v. Cottrell – New Jersey
District Court: District of New Jersey Status: Decided
Consumers brought putative class action against manufacturers and distributors of prescription eye medication, alleging they packaged medication in such a way as to force consumers …
In re Express Scripts/Anthem ERISA Litigation – New York
District Court: Southern District of New York Status: Pending
The district court dismissed a proposed class action against Anthem Inc. and Express Scripts Inc. over drug pricing methods, holding that the companies can’t be …
PhRMA and BIO v. Sandoval – Nevada
District Court: District of Nevada Status: Decided
In September 2017, just three months after Nevada passed its insulin transparency law (SB 539) in June 2017 to increase transparency over the price of …
Association for Accessible Medicines v. Frosh – Maryland
District Court: District of Maryland Status: Decided
In a significant victory for the pharmaceutical industry, the 4th U.S. Circuit Court of Appeals found Maryland’s landmark 2017 law (HB 631), which punishes generic …
Next | See all Litigation Records
News & Opinions
Articles & Reports
The Commonwealth Fund
September 29, 2022
Congressional Budget Office September 29, 2022
The Commonwealth Fund September 22, 2022
Families USA’s People First Care September 15, 2022
Congressional Budget Office September 29, 2022
The Commonwealth Fund September 22, 2022
Families USA’s People First Care September 15, 2022